EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

Laventa M Obare, Tecla Temu iD, Simon A Mallal, Celestine N Wanjalla

Circulation Research · 24.05.2024 · 134 (11) · 1515-1545

DOI: 10.1161/circresaha.124.323891 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 24.05.2024. Verfasst von Laventa M Obare und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN (L.M.O., S.A.M., C.N.W.). Hauptthemen laut MEDLINE: HIV Infections, Atherosclerosis, Inflammation. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 358 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with HIV have a 1.5- to 2-fold increased risk of developing cardiovascular disease. Despite treatment with highly effective antiretroviral therapy, people living with HIV have chronic inflammation that makes them susceptible to multiple comorbidities. Several factors, including the HIV reservoir, coinfections, clonal hematopoiesis of indeterminate potential (CHIP), microbial translocation, and antiretroviral therapy, may contribute to the chronic state of inflammation. Within the innate immune system, macrophages harbor latent HIV and are among the prominent immune cells present in atheroma during the progression of atherosclerosis. They secrete inflammatory cytokines such as IL (interleukin)-6 and tumor necrosis-α that stimulate the expression of adhesion molecules on the endothelium. This leads to the recruitment of other immune cells, including cluster of differentiation (CD)8 + and CD4 + T cells, also present in early and late atheroma. As such, cells of the innate and adaptive immune systems contribute to both systemic inflammation and vascular inflammation. On a molecular level, HIV-1 primes the NLRP3 (NLR family pyrin domain containing 3) inflammasome, leading to an increased expression of IL-1β, which is important for cardiovascular outcomes. Moreover, activation of TLRs (toll-like receptors) by HIV, gut microbes, and substance abuse further activates the NLRP3 inflammasome pathway. Finally, HIV proteins such as Nef (negative regulatory factor) can inhibit cholesterol efflux in monocytes and macrophages through direct action on the cholesterol transporter ABCA1 (ATP-binding cassette transporter A1), which promotes the formation of foam cells and the progression of atherosclerotic plaque. Here, we summarize the stages of atherosclerosis in the context of HIV, highlighting the effects of HIV, coinfections, and antiretroviral therapy on cells of the innate and adaptive immune system and describe current and future interventions to reduce residual inflammation and improve cardiovascular outcomes among people living with HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAtherosclerosisInflammationHumansAnimalsImmunity, Innate

Stichwörter der Autor:innen

HIVatherosclerosiscardiovascular diseasesclinical relevanceendothelial cellsinflammationrisk factors

Autor:innen und Institutionen

  • Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN (L.M.O., S.A.M., C.N.W.).
  • Department of Pathology, Harvard Medical School, Boston, MA (T.T.).
  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN (S.A.M.).
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN (S.A.M.).
  • Institute for Immunology and Infectious Diseases, Murdoch University, WA, Western Australia (S.A.M.).

ORCID-Profile: Tecla Temu

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Obare, L. M., Temu, T., Mallal, S. A., & Wanjalla, C. N. (2024). Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease. Circulation Research, 134(11), 1515-1545. https://doi.org/10.1161/circresaha.124.323891

Vancouver

Obare LM, Temu T, Mallal SA, Wanjalla CN. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease. Circulation Research. 2024;134(11):1515-1545. doi:10.1161/circresaha.124.323891

BibTeX
@article{Obare2024,
  author = {Obare, Laventa M and Temu, Tecla and Mallal, Simon A and Wanjalla, Celestine N},
  title = {Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease},
  journal = {Circulation Research},
  year = {2024},
  volume = {134},
  number = {11},
  pages = {1515--1545},
  doi = {10.1161/circresaha.124.323891}
}
Kostenlos starten →